Volume 59, Issue 6, Pages (December 2013)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 60, Issue 1, Pages (January 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 4, Pages (October 2009)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Volume 67, Issue 3, Pages (September 2017)
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Liver transplantation using Donation after Cardiac Death donors
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Issue Highlights Clinical Gastroenterology and Hepatology
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 63, Issue 4, Pages (April 2013)
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Volume 80, Issue 1, Pages (July 2011)
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 3, Pages (September 2014)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 79, Issue 12, Pages (June 2011)
Volume 50, Issue 2, Pages (February 2009)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults  Mark P. Purdue, Laura E. Beane Freeman, William F. Anderson, Margaret.
Volume 67, Issue 6, Pages (December 2017)
Economics of chronic hepatitis B and hepatitis C
Volume 65, Issue 2, Pages (August 2016)
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 67, Issue 3, Pages (September 2017)
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
Immunological techniques in viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
Serum HBV pgRNA as a clinical marker for cccDNA activity
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Genetics of hepatocellular carcinoma: The next generation
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant  Ryan R. Davies, MD, Shylah Haldeman,
Presentation transcript:

Volume 59, Issue 6, Pages 1177-1183 (December 2013) Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, The Netherlands  Gini van Rijckevorsel, Jane Whelan, Mirjam Kretzschmar, Evelien Siedenburg, Gerard Sonder, Ronald Geskus, Roel Coutinho, Anneke van den Hoek  Journal of Hepatology  Volume 59, Issue 6, Pages 1177-1183 (December 2013) DOI: 10.1016/j.jhep.2013.08.002 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Acute HBV in MSM in Amsterdam (1992–2011). (A) Incidence (per 100,000 MSM) per calendar year. The measured incidence is represented by the line with dots, and the fitted incidence by the smooth line with its 95% confidence interval (striped area). The grey shaded area is the population denominator data of the Amsterdam MSM population. (B) Age-specific rate (per 100,000 MSM). (C) Year of birth-specific rate (per 100,000 person years). The measured rate is represented by dots and the fitted rate by the smooth line with its 95% confidence interval (striped area). py, person years. Journal of Hepatology 2013 59, 1177-1183DOI: (10.1016/j.jhep.2013.08.002) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Acute HBV rates. (A) Age-specific and (B) year of birth-specific rates of acute HBV per 100,000 person years in MSM in Amsterdam stratified by 4 periods of diagnosis (‘92–‘96, ‘97–‘01, ‘02–‘06, ‘07–‘11). py, person years. Journal of Hepatology 2013 59, 1177-1183DOI: (10.1016/j.jhep.2013.08.002) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Results from the multivariable APC-analysis of the acute HBV incidence per 100,000 MSM in Amsterdam, the Netherlands 1992–2011, shown as line graphs representing log rates, with its 95% confidence interval (grey shaded area). (A) Age-specific rates adjusted for period (per 100,000 person-years on left Y-axis) for the 1966 birth cohort, which peaks at age 20 and 40. (B) The cohort effect adjusted for age and period (calendar year vs. rate ratio on the right Y-axis). The highest rate is in the 1966 birth cohort, i.e., all other rates ratios are <1. (C) The period effect (the non-linear effects of period unexplained by the other two terms) acts like a residual effect. py, person years. Journal of Hepatology 2013 59, 1177-1183DOI: (10.1016/j.jhep.2013.08.002) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Effect of vaccination and increased sexual risk behaviour on the incidence of acute HBV. The endemic equilibrium (black solid line) is based on the incidence of notified acute HBV 1992–1998 before the initiation of vaccination and changes in sexual risk behaviour. Scenario 1: (green line): effect of increasing sexual behaviour from 1997 to 2004 if no MSM were vaccinated. Scenario 2: (red line) the effect of the vaccination programme targeting all MSM. Scenario 3: (black line) the effect of the vaccination programme targeting high-risk MSM only. py, person years. Journal of Hepatology 2013 59, 1177-1183DOI: (10.1016/j.jhep.2013.08.002) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions